|
|
|
|
| LEADER |
00000cam a22000002 4500 |
| 001 |
1091133778 |
| 003 |
DE-627 |
| 005 |
20230427063757.0 |
| 007 |
tu |
| 008 |
900726s1982 xx ||||| 00| ||eng c |
| 024 |
8 |
|
|a SCNAC-97-1-9
|q Sonstige Nr.
|
| 035 |
|
|
|a (DE-627)1091133778
|
| 035 |
|
|
|a (DE-576)021133778
|
| 035 |
|
|
|a (DE-599)BSZ021133778
|
| 035 |
|
|
|a (OCoLC)311291734
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 245 |
1 |
0 |
|a Federal drug strategy
|b 1981; hearing before the Select Committee on Narcotics Abuse and Control, (U.S.) House ... 97:1, November 19, 1981
|
| 264 |
|
1 |
|a Washington, DC
|b U.S. Gov. Print. Office
|c 1982
|
| 300 |
|
|
|a 54 S.
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
| 338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
| 583 |
1 |
|
|a Archivierung prüfen
|c 20200919
|f DE-640
|z 2
|2 pdager
|
| 710 |
2 |
|
|a USA
|b Congress
|b House of Representatives
|b Select Committee on Narcotics Abuse and Control
|0 (DE-588)1048583-1
|0 (DE-627)100142443
|0 (DE-576)191429007
|4 oth
|
| 951 |
|
|
|a BO
|
| ELC |
|
|
|b 1
|
| LOK |
|
|
|0 000 xxxxxcx a22 zn 4500
|
| LOK |
|
|
|0 001 2148291769
|
| LOK |
|
|
|0 003 DE-627
|
| LOK |
|
|
|0 004 1091133778
|
| LOK |
|
|
|0 005 19900726000000
|
| LOK |
|
|
|0 008 900726||||||||||||||||ger|||||||
|
| LOK |
|
|
|0 040
|a DE-21
|c DE-627
|d DE-21
|
| LOK |
|
|
|0 852
|a DE-21
|
| LOK |
|
|
|0 852 1
|c KB 6 E 95
|9 00
|
| LOK |
|
|
|0 935
|a krim
|
| LOK |
|
|
|0 936ln
|a k1
|
| ORI |
|
|
|a SA-MARC-krimdoka001.raw
|
| SIG |
|
|
|a UB: KB 6 E 95
|
